Vimarsana
Biggest News Aggregation in the World

Page 2 - Nasdaq Knte News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq Knte. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Knte Today - Breaking & Trending Today

Q3 2023 EPS Estimates for Kinnate Biopharma Inc. Increased by HC Wainwright (NASDAQ:KNTE) - Vimarsana News

Q3 2023 EPS Estimates for Kinnate Biopharma Inc. Increased by HC Wainwright (NASDAQ:KNTE)

Kinnate Biopharma Inc. (NASDAQ:KNTE – Free Report) – Stock analysts at HC Wainwright increased their Q3 2023 earnings per share estimates for shares of Kinnate Biopharma in a report released on Tuesday, August 15th. HC Wainwright analyst R. Burns now anticipates that the company will earn ($0.73) per share for the quarter, up from their […]

Kinnate Biopharma (NASDAQ:KNTE) Stock Rating Reaffirmed by 500.com - Vimarsana News

Kinnate Biopharma (NASDAQ:KNTE) Stock Rating Reaffirmed by 500.com

Kinnate Biopharma (NASDAQ:KNTE – Get Rating)‘s stock had its “maintains” rating reaffirmed by research analysts at 500.com in a research report issued on Thursday, Benzinga reports. Other analysts also recently issued reports about the company. The Goldman Sachs Group decreased their price target on Kinnate Biopharma from $29.00 to $26.00 and set a “buy” rating […]

Kinnate Biopharma (NASDAQ:KNTE) Receives Maintains Rating from 500.com - Vimarsana News

Kinnate Biopharma (NASDAQ:KNTE) Receives Maintains Rating from 500.com

500.com restated their maintains rating on shares of Kinnate Biopharma (NASDAQ:KNTE – Get Rating) in a report released on Thursday, Benzinga reports. A number of other brokerages have also commented on KNTE. Stifel Nicolaus dropped their price target on Kinnate Biopharma from $8.00 to $5.00 in a research note on Tuesday, April 18th. HC Wainwright […]

Source: wkrb13.com
Kinnate Biopharma (NASDAQ:KNTE) Price Target Cut to $24.00 by Analysts at HC Wainwright - Vimarsana News

Kinnate Biopharma (NASDAQ:KNTE) Price Target Cut to $24.00 by Analysts at HC Wainwright

Kinnate Biopharma (NASDAQ:KNTE – Get Rating) had its price objective trimmed by HC Wainwright from $25.00 to $24.00 in a research note released on Thursday morning, The Fly reports. A number of other research analysts have also recently issued reports on the company. Wedbush reduced their price objective on Kinnate Biopharma from $25.00 to $14.00 […]

Source: wkrb13.com
Short Interest in Kinnate Biopharma Inc. (NASDAQ:KNTE) Decreases By 16.6% - Vimarsana News

Short Interest in Kinnate Biopharma Inc. (NASDAQ:KNTE) Decreases By 16.6%

Kinnate Biopharma Inc. (NASDAQ:KNTE – Get Rating) was the target of a significant decline in short interest in the month of April. As of April 30th, there was short interest totalling 1,510,000 shares, a decline of 16.6% from the April 15th total of 1,810,000 shares. Approximately 6.9% of the shares of the company are sold […]